Clinical Observation of Thyroid Cancer Treated by CAF Regimen Combined with Fufangbanmao Capsule
July 2023
in “
International Journal of Clinical and Experimental Medicine Research
”
Studysummary This study found that for thyroid cancer patients who underwent radical mastectomy, the combination of CAF regimen and fufangbanmao capsule improved short-term clinical efficacy, enhanced immune function, reduced drug toxicity, and positively impacted quality of life compared to the CAF regimen alone.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The study investigated the clinical effects of combining the CAF regimen with fufangbanmao capsules in treating thyroid cancer in 118 patients who underwent radical mastectomy. Patients were divided into two groups: one received the combined treatment, and the other received only the CAF regimen. The combined treatment group showed significantly better outcomes, with an objective response rate (ORR) of 91.53% and a disease control rate (DCR) of 96.61%, compared to 76.27% and 83.05% in the control group, respectively. Additionally, the combined treatment improved immune function, quality of life, and reduced drug toxicity, including lower incidences of joint pain, bone marrow suppression, and other side effects. The study concludes that the combination therapy enhances short-term efficacy and reduces toxicity in thyroid cancer patients post-surgery.
